Copper deficiency and HbA1c are linked in a clinically important but often overlooked way. Copper is an essential trace element required for healthy red blood cell production, and when levels fall, erythropoiesis can become impaired — potentially altering the average age of circulating red blood cells. Because HbA1c reflects glycation accumulated over a red blood cell's lifespan, any disruption to red blood cell turnover can affect the reliability of this widely used diabetes marker. This article explains the mechanism behind this interaction, identifies at-risk groups in the UK, and outlines when to investigate further.

How Copper Deficiency Affects Red Blood Cell Turnover

Copper deficiency impairs erythropoiesis by disrupting iron mobilisation and haemoglobin synthesis, reducing effective red blood cell production; bone marrow changes can resemble myelodysplastic features, and neutropenia is a recognised associated finding.

Have any more questions about this? Message our pharmaceutical team to get more info →

Copper is an essential trace element that plays an important role in numerous physiological processes, including the production and maturation of red blood cells (erythrocytes). It acts as a cofactor for several enzymes, most notably ceruloplasmin and cytochrome c oxidase, which are involved in iron metabolism and cellular energy production. Without adequate copper, the body struggles to mobilise iron from storage sites, impairing haemoglobin synthesis and contributing to a form of anaemia that can resemble iron-deficiency anaemia.

When copper levels are insufficient, red blood cell production in the bone marrow can become disrupted — a process known as ineffective erythropoiesis. Bone marrow findings in copper deficiency can sometimes mimic myelodysplastic changes, and associated neutropenia is a recognised feature. Whether copper deficiency consistently shortens red blood cell lifespan through haemolysis is less certain; the evidence is limited and variable, and haemolysis is not a universal feature of copper deficiency.

Normally, red blood cells survive for approximately 90–120 days in the circulation, and it is this lifespan that underpins the clinical utility of HbA1c as a marker of longer-term blood glucose control. If red blood cell production is impaired or turnover is increased — for whatever reason — the average age of circulating red blood cells may fall. This shift has potential implications for how HbA1c values are interpreted, as discussed in the following section. Understanding this mechanism is important for clinicians and patients who may be monitoring diabetes or prediabetes using HbA1c as their primary diagnostic or monitoring tool.

The Link Between Copper Deficiency and HbA1c Readings

Copper deficiency can produce a lower-than-expected HbA1c by reducing the average age of circulating red blood cells, meaning less glycated haemoglobin accumulates even when blood glucose is consistently elevated.

HbA1c (glycated haemoglobin) is formed when glucose in the bloodstream binds irreversibly to haemoglobin within red blood cells. The longer a red blood cell circulates, and the higher the ambient blood glucose, the greater the degree of glycation. A standard HbA1c test therefore provides an integrated picture of blood glucose control over the preceding two to three months — but only when red blood cell lifespan is within the normal range.

Copper deficiency may interfere with this relationship in a clinically meaningful way. By contributing to impaired erythropoiesis or, in some cases, increased red blood cell turnover, copper deficiency can reduce the average age of red blood cells in circulation. Younger red blood cells have had less time to accumulate glycated haemoglobin, even if blood glucose levels have been consistently elevated. The potential result is a lower-than-expected HbA1c , which may not accurately reflect glycaemic control. However, it is important to note that the direction and magnitude of this effect can vary depending on the degree of anaemia and the individual's red blood cell kinetics; a consistently falsely low result should not be assumed in every case.

There is no established direct biochemical interaction between copper and the glycation process itself. The effect on HbA1c is considered indirect, mediated through copper's impact on red blood cell production and survival. The clinical evidence is largely limited to case reports and small observational studies, and robust prospective data are lacking.

NICE NG28 and the WHO 2011 report on the use of HbA1c for the diagnosis of diabetes both acknowledge that HbA1c is unsuitable as a diagnostic or monitoring tool in a range of conditions affecting red blood cell lifespan or haemoglobin structure. RCPath and the Association for Clinical Biochemistry (ACB) provide UK laboratory guidance on conditions and assay-related factors that can affect HbA1c reliability. Clinicians should be aware that:

• An unexpectedly low HbA1c in a patient with known hyperglycaemia warrants further investigation

• Concurrent anaemia, particularly with features of both iron and copper deficiency, should raise suspicion

• When HbA1c is considered unreliable, fasting plasma glucose (FPG) or an oral glucose tolerance test (OGTT) are the recommended diagnostic alternatives (per NICE NG28 and WHO 2011); capillary blood glucose profiles can support monitoring

• Fructosamine or glycated albumin testing, available through some NHS laboratories, may provide an indication of shorter-term glycaemic trends (approximately two to three weeks), though interpretation requires laboratory guidance

• Access to continuous glucose monitoring (CGM) or flash glucose monitoring in the NHS is subject to NICE criteria and local commissioning policies, and is typically arranged via specialist diabetes services

Conditions That Cause Copper Deficiency in the UK

The most common causes of copper deficiency in the UK are bariatric surgery, malabsorptive conditions such as coeliac disease or Crohn's disease, and excessive long-term zinc supplementation above 25 mg per day.

Copper deficiency is relatively uncommon in the general UK population, but it is more prevalent in specific clinical groups. Recognising these at-risk populations is important for identifying patients whose HbA1c results may be unreliable.

Common causes of copper deficiency in the UK include:

• Bariatric surgery — particularly Roux-en-Y gastric bypass, which significantly reduces the absorptive surface area of the upper gastrointestinal tract where copper is primarily absorbed. This is one of the most frequently reported causes in clinical practice. The British Obesity and Metabolic Surgery Society (BOMSS) 2020 guidelines recommend routine monitoring of micronutrients, including copper, following bariatric procedures.

• Malabsorptive conditions — such as coeliac disease, Crohn's disease, and short bowel syndrome, all of which impair nutrient absorption broadly.

• Excessive zinc supplementation — zinc and copper compete for the same intestinal transporter (metallothionein). High-dose zinc supplements can significantly reduce copper absorption. The Scientific Advisory Committee on Nutrition (SACN) and NHS guidance indicate that long-term zinc supplementation above 25 mg per day carries a risk of copper depletion; individuals should not exceed this level without medical supervision.

• Prolonged parenteral or enteral nutrition — if copper is not adequately supplemented in feeds, deficiency can develop over weeks to months. BAPEN guidance addresses trace element provision in nutritional support.

• Iatrogenic causes — medications such as penicillamine or trientine, used in the management of Wilson's disease, can reduce copper levels as part of their therapeutic action.

• Nephrotic syndrome — urinary losses of copper-binding proteins have been reported to contribute to copper depletion in some cases, though this is an uncommon cause and the evidence base is limited.

Despite BOMSS and NHS nutritional support pathways recommending routine micronutrient monitoring in relevant patient groups, copper deficiency remains underdiagnosed, partly because its symptoms — fatigue, anaemia, and neurological changes — overlap with many other conditions. Awareness among both primary and secondary care clinicians is therefore important, particularly when interpreting metabolic investigations such as HbA1c in these patient groups.

When HbA1c May Give Misleading Results

Copper deficiency is associated with a lower-than-expected HbA1c; NICE NG28 and WHO 2011 guidance specify that glucose-based alternatives should be used when HbA1c reliability is in doubt.

HbA1c is a robust and widely used diagnostic tool, endorsed by NICE (NG28) and the World Health Organisation for both the diagnosis and monitoring of type 2 diabetes. However, it is not suitable in all circumstances. NICE NG28 and the WHO 2011 diagnostic report specify that HbA1c should not be used for diagnosis in pregnancy, in children and young people, in individuals with suspected type 1 diabetes, or when symptoms of acute hyperglycaemia are present. A range of conditions can also render HbA1c unreliable as a monitoring tool, and clinicians must be alert to these scenarios.

Conditions associated with a lower-than-expected HbA1c:

• Haemolytic anaemia (any cause)

• Copper deficiency anaemia (via impaired erythropoiesis and, in some cases, increased red blood cell turnover)

• Recent blood transfusion

• Haemoglobin variants (e.g., HbS, HbC) — the direction of interference depends on the assay method used

• Chronic kidney disease (due to reduced red blood cell lifespan)

Conditions associated with a higher-than-expected HbA1c:

• Iron-deficiency anaemia (in certain assay methods)

• Vitamin B12 or folate deficiency

• Splenectomy (prolonged red blood cell survival)

• Certain haemoglobin variants

It is worth noting that the effect of iron deficiency and haemoglobin variants on HbA1c is assay-dependent; UK laboratories can advise on method-specific interferences, and RCPath/ACB guidance provides further detail.

In the context of copper deficiency, the concern is predominantly a lower-than-expected HbA1c, which could lead a clinician or patient to believe that blood glucose is better controlled than it actually is. This is particularly relevant in individuals with type 2 diabetes managed in primary care based largely on HbA1c trends. If a patient's self-monitored blood glucose readings or symptoms suggest poor control, but their HbA1c appears reassuringly normal or low, an underlying cause such as copper deficiency should be considered. NICE NG28, WHO 2011, and RCPath/ACB guidance all emphasise that HbA1c should be interpreted alongside clinical context rather than in isolation, and that glucose-based alternatives (FPG or OGTT) should be used when HbA1c is considered unreliable.

Investigating Unexpectedly Low or High HbA1c Values

Investigation should include full blood count, serum copper and ceruloplasmin, serum zinc, iron studies, and vitamin B12/folate; fasting plasma glucose or OGTT should be used for diabetes assessment when HbA1c is unreliable.

When an HbA1c result does not align with a patient's clinical picture — for example, a lower-than-expected HbA1c in someone with consistently elevated home blood glucose readings — a structured investigative approach is warranted. This begins with a thorough clinical history, including dietary habits, surgical history, medication use (particularly zinc supplements or copper-chelating agents), and any symptoms suggestive of anaemia, malabsorption, or neurological change.

Recommended investigations may include:

• Full blood count (FBC) — to identify anaemia and assess red blood cell indices such as mean corpuscular volume (MCV) and mean corpuscular haemoglobin (MCH); neutropenia may also be present in copper deficiency

• Reticulocyte count — elevated reticulocytes suggest increased red blood cell turnover, consistent with haemolysis or recovery from anaemia

• Haemolysis screen — where haemolysis is suspected, this should include lactate dehydrogenase (LDH), unconjugated bilirubin, haptoglobin, and a direct antiglobulin test (DAT)

• Serum copper and ceruloplasmin — the primary tests for copper status; ceruloplasmin is the main copper-carrying protein in the blood

• Serum zinc — to assess for excess zinc, which may be suppressing copper absorption

• Serum ferritin, iron studies, and vitamin B12/folate — to exclude other nutritional causes of anaemia that may affect HbA1c

• Coeliac serology — tissue transglutaminase IgA (tTG-IgA) with total IgA, where malabsorption is suspected

• Haemoglobin electrophoresis — if a haemoglobin variant is suspected as a cause of HbA1c interference

When HbA1c is considered unreliable, NICE NG28 and WHO 2011 recommend using fasting plasma glucose (FPG) or an oral glucose tolerance test (OGTT) for diagnostic purposes, and capillary blood glucose profiles for monitoring. Fructosamine or glycated albumin, available through some NHS laboratories, may offer an indication of shorter-term glycaemic trends.

If copper deficiency is confirmed, the underlying cause should be identified and addressed. Oral copper supplementation is typically the first-line treatment; dosing and monitoring should follow specialist or local NHS guidance (such as BOMSS recommendations following bariatric surgery, or BAPEN guidance in the context of nutritional support). Intravenous copper replacement should only be undertaken under specialist supervision, given the risk of toxicity. Dietary sources of copper — including shellfish, nuts, seeds, and wholegrains — should be encouraged where appropriate and tolerated.

When to Seek Advice From Your GP or Specialist

Patients who have had bariatric surgery, take high-dose zinc supplements, or have a malabsorptive condition and notice a discrepancy between home glucose readings and HbA1c should contact their GP for further assessment.

Most people will not need to consider copper deficiency as a factor in their diabetes management. However, there are specific circumstances in which it is important to seek timely medical advice, particularly if you are in a higher-risk group or have received an unexpected HbA1c result.

Seek urgent same-day medical attention if you experience:

• Rapidly progressive weakness, numbness, or difficulty walking, which may indicate significant neurological involvement

• Symptoms of severe anaemia such as chest pain, breathlessness at rest, or feeling faint

• Symptoms of markedly elevated blood glucose such as excessive thirst, frequent urination, vomiting, or confusion

Contact your GP if you:

• Have had bariatric surgery and have not had recent micronutrient blood tests, including copper, in line with BOMSS follow-up recommendations

• Are taking zinc supplements above 25 mg per day on a long-term basis (the level above which copper depletion may occur, per SACN/NHS guidance)

• Have a known malabsorptive condition such as coeliac disease or Crohn's disease and are experiencing new or worsening fatigue, weakness, or symptoms of anaemia

• Have diabetes and notice that your home blood glucose readings are consistently higher than your HbA1c result would suggest

• Experience unexplained neurological symptoms such as numbness, tingling, or unsteadiness, which can also be features of copper deficiency

Referral to a specialist may be appropriate if:

• Copper deficiency is confirmed and an underlying cause has not been identified

• Oral supplementation has not corrected deficiency, suggesting significant malabsorption requiring specialist input

• Glycaemic management is complicated by unreliable HbA1c results, in which case referral to a diabetes specialist team may be beneficial; access to continuous glucose monitoring (CGM) or flash monitoring follows NICE criteria and local NHS commissioning policies, and is typically arranged via specialist services

It is always advisable to discuss any concerns about your blood test results with a healthcare professional rather than adjusting medications or supplements independently. Your GP can coordinate appropriate investigations and, where necessary, refer you to relevant secondary care services including endocrinology, gastroenterology, or a specialist diabetes team. Early identification of copper deficiency not only helps ensure accurate diabetes monitoring but also prevents the broader health consequences of this underrecognised nutritional deficiency.

Frequently Asked Questions